6810--Isotopes Ca-43 and Ca-44
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically Network Contracting Office (NCO) 21, intends to award a sole source, firm-fixed-price contract to Trace Sciences for Calcium Isotopes Ca-43 and Ca-44. This procurement is on behalf of the San Francisco VA Medical Center. While a sole source is intended, other responsible sources are encouraged to submit capability statements. Responses are due by Thursday, February 5, 2026, at 12:00 PM Pacific time.
Scope of Work
This opportunity requires the provision of specific calcium isotopes:
- Item 0001: 610.00 MG of Calcium 44 stable isotope, 99%+ enrichment, in carbonate form (MPN: Ca44).
- Item 0002: 40.00 MG of Calcium 43 stable isotope, 86%+ enrichment, in carbonate form (MPN: Ca43).
Contract & Timeline
- Contract Type: Firm-Fixed-Price
- NAICS Code: 325180 - Other Basic Inorganic Chemical Manufacturing
- Product/Service Code: 6810 - Chemicals
- Set-Aside: None (Intent to Sole Source)
- Solicitation Posting: On or about February 4, 2026, on SAM.gov.
- Response Due: February 5, 2026, 12:00 PM Pacific time.
- Published: February 3, 2026.
Eligibility & Submission
Vendors must be an OEM, authorized dealer, authorized distributor, or authorized reseller for the specified items. Submissions must include documentation demonstrating this authority and compliance with VAAR 852.212-71 and VAAR 852.212-72 (Gray Market Items). Responses should be sent via email to Shelley.Self2@va.gov.
Evaluation
The VA will consider all submitted capability statements, proposals, or quotations to determine whether to proceed with the sole source acquisition. Failure to provide required documentation may result in a determination that a company is not a viable source.
Additional Notes
The VA prioritizes patient care and choice in its decision-making process.